Even if leukemic cells are sensitive to allogeneic NK-cell-mediated lysis, alterations in the expression of some activating receptors, including NCR and DNAM-1, on the autologous NK cells suggest that NK-to-AML interactions can be defective in patients. The gene discussed is CD226; the disease is acute myeloid leukemia.